Inhibrx Biosciences
Price & Volume
Stats
See moreOpen | $120.67 |
Previous Close | $123.93 |
Day Range | $120.02-$123.57 |
52W Range | $26.19-$155.29 |
Market Cap | $1.8B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$103M |
Diluted EPS | -$9.05 |
News
See moreYahoo Finance • 4 months ago
Inhibrx Biosciences (INBX) Announces Positive Interim Results From Phase 2 Portion of HexAgon Study
Yahoo Finance • 4 months ago
Merck Broadens KEYTRUDA Collaborations As Patent Expiry Pressure Builds
Yahoo Finance • 4 months ago
T-Mobile reportedly in merger talks, Adobe's $25B stock buyback
Yahoo Finance • 5 months ago
Inhibrx gains as Stifel issues new Buy based on lead assets
About
CEO | Mr. Mark Paul Lappe |
CFO | Ms. Kelly Devine Deck B.S., CPA, M.S. |
Address | 11025 North Torrey Pines Road, La Jolla, CA, United States, 92037 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 109 |